Shortage Status

Status

Date Posted

Date Posted (dd-mm-yyyy)

  • DEPO-RALOVERA medroxyprogesterone acetate 150 mg/1 mL

    Availability: Unavailable Deletion from market: 01 Jul 2024

  • MS MONO morphine sulfate pentahydrate 30mg

    Availability: Unavailable Deletion from market: 10 May 2024

  • RADPHARM HDP sodium oxidronate 3.15 mg

    Availability: Unavailable
    View Detail

  • REPATHA evolocumab (rch) 420 mg/3.5 mL

    Availability: Reduction in supply until supply is exhausted Deletion from market: 14 Jul 2024

  • IDACIO adalimumab (rch) 40 mg

    Availability: Unavailable Deletion from market: 01 Aug 2024

  • IDACIO adalimumab (rch) 40 mg

    Availability: Unavailable Deletion from market: 01 Aug 2024

  • ANAPEN 300 adrenaline (epinephrine) 300 microgram

    Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Jul 2024

  • ANAPEN JUNIOR 150 adrenaline (epinephrine) 150 microgram

    Availability: Reduction in supply until supply is exhausted Deletion from market: 27 Sep 2024

  • Pfizer (Australia) METHOTREXATE 50mg/2mL

    Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Dec 2024
    View Detail

  • SITAGLIPTIN LUPIN sitagliptin (as hydrochloride monohydrate) 25 mg

    Availability: Unavailable Deletion from market: 14 Jun 2024

  • SITAGLIPTIN LUPIN sitagliptin (as hydrochloride monohydrate) 50 mg

    Availability: Unavailable Deletion from market: 14 Jun 2024

  • SITAGLIPTIN LUPIN sitagliptin (as hydrochloride monohydrate) 100 mg

    Availability: Unavailable Deletion from market: 14 Jun 2024